Biotechnology Assets Revenue

In the year 2025, Biotechnology Assets had annual revenue of 3.09M EUR, down -2.10%. Biotechnology Assets had revenue of 2.11M in the half year ending December 31, 2025, a decrease of -2.80%. That makes Biotechnology Assets the 40,812th largest company in the world by revenue and 190th in Spain.

Revenue

3.09M

Revenue Growth

-2.10%

P/S Ratio

4.46

Revenue / Employee

131.99K

Employees

Market Cap

14.71M

Revenue Chart

Chart

Revenue by Geography

Chart

Europe 2.54M 82.1%
America 529.44K 17.1%
Asia 22.87K 0.7%

Fiscal year ended Dec 31, 2025 See the full Biotechnology Assets breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	3.09M	-66.33K	-2.10%
Dec 31, 2024	3.16M	2.63M	494.28%
Dec 31, 2023	531.24K	-2.08M	-79.68%
Dec 31, 2022	2.61M	-471.56K	-15.28%
Dec 31, 2021	3.09M	560.72K	22.21%
Dec 31, 2020	2.52M	394.94K	18.54%
Dec 31, 2019	2.13M	-21.19M	-90.87%
Dec 31, 2018	23.32M	11.09M	90.67%
Dec 31, 2017	12.23M	10.92M	831.88%
Dec 31, 2016	1.31M	261.91K	24.94%
Dec 31, 2015	1.05M	-830.20K	-44.15%
Dec 31, 2014	1.88M	1.01M	116.04%
Dec 31, 2013	870.46K	427.29K	96.42%
Dec 31, 2012	443.17K	154.02K	53.27%
Dec 31, 2011	289.15K	151.18K	109.57%
Dec 31, 2010	137.97K	-285.03K	-67.38%
Dec 31, 2009	423.00K	193.00K	83.91%
Dec 31, 2008	230.00K	-	-

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.

Related Stocks

Company Name	Revenue
Grifols	7.42B
Almirall	1.16B
Laboratorios Farmaceuticos Rovi	773.05M
Faes Farma	711.06M
Laboratorio Reig Jofre	337.73M
Prim, S.A.	250.65M
Atrys Health	147.68M
Labiana Health	76.44M

Revenue Rankings